Stocks Above the 200-Day Moving Average — Valuation View · Services-Medical Laboratories
16 stocks match the Stocks Above the 200-Day Moving Average screen. Stocks trading above their 200-day moving average — a long-term uptrend filter, largest first. Valuation columns. Filtered to Services-Medical Laboratories. Updated
Filters2
1–16 of 16
| NTRA | Natera, Inc. | $47.2B | -245.26 | 17.43 | 25.90 | 43.22 | — | 327.28 | +0.66% | 33K |
| LH | Labcorp | $26.9B | 26.82 | 1.87 | 3.12 | 189.58 | 0.9% | 331.48 | -0.07% | 28K |
| DGX | Quest Diagnostics | $26.4B | 24.88 | 2.29 | 3.52 | 42.20 | 1.4% | 239.37 | -0.58% | 45K |
| GH | Guardant Health, Inc. | $21.6B | -47.65 | 18.26 | — | 20.51 | — | 161.01 | -1.23% | 73K |
| CAI | Caris Life Sciences, Inc. | $7.2B | 68.06 | 7.23 | 12.09 | 8.73 | — | 25.32 | +2.14% | 432K |
| RDNT | Radnet, Inc. | $5.9B | -278.18 | 2.59 | 5.36 | 8.09 | — | 74.64 | -1.36% | 82K |
| BLLN | Billiontoone, Inc. | $4.6B | 121.86 | 11.56 | 8.56 | 8.38 | — | 99.54 | +3.64% | 42K |
| GRAL | Grail, Inc. | $3.6B | -9.19 | — | 1.41 | 64.64 | — | 80.53 | +0.03% | 17K |
| VCYT | Veracyte, Inc. | $3.6B | 31.35 | 6.39 | 2.58 | 11.98 | — | 44.64 | -0.65% | 33K |
| CDNA | Caredx, Inc. | $2.6B | 23.22 | 5.63 | 6.06 | 6.90 | — | 49.84 | +0.44% | 39K |
| PSNL | Personalis, Inc. | $1.8B | -16.77 | — | 7.64 | 19.13 | — | 16.83 | +0.51% | 133K |
| FTRE | Fortrea Holdings Inc. | $1.8B | -20.77 | 0.66 | 3.38 | 10.50 | — | 18.61 | +1.47% | 45K |
| CSTL | CASTLE BIOSCIENCES INC | $998M | -51.41 | 2.79 | 2.12 | 16.07 | — | 32.67 | -2.17% | 13K |
| BDSX | BIODESIX INC | $279M | -10.04 | 2.71 | 30.47 | 9.29 | — | 26.41 | -2.76% | 3K |
| XGN | EXAGEN INC. | $183M | -9.65 | 2.57 | 14.95 | 7.43 | — | 7.54 | +0.13% | 16K |
| ADVB | Advanced Biomed Inc. | $13M | 2.52 | — | 1.45 | 5.11 | — | 9.63 | +0.31% | 151 |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.